Stock Market Reviews

Read and share opinions on RLAY (Relay Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
  Nov 6, 2025
• Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
  Nov 3, 2025
• Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
  Oct 30, 2025
• Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a Bet
  Oct 30, 2025
• Here's Why Relay Therapeutics, Inc. (RLAY) is a Great Momentum Stock to Buy
  Oct 28, 2025
• Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to Trade
  Oct 14, 2025
• Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608
  Sep 21, 2025
• Guggenheim Gives Buy Rating to Relay Therapeutics (RLAY)
  Sep 8, 2025
• Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
  Aug 28, 2025
• Leerink Partners Reiterates a Buy Rating on Relay Therapeutics (RLAY) With a $12 PT
  Aug 26, 2025
• Raymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost Cuts
  Aug 18, 2025
• Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock?
  Aug 12, 2025
• Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates
  Aug 7, 2025
• Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
  Aug 7, 2025
• Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
  Jul 31, 2025